RB Global, Inc. filings document the regulatory record for a Canadian public company whose common shares trade under RBA and whose business centers on commercial-asset and vehicle marketplaces. The company’s reports cover operating results, gross transaction value, revenue categories, dividends, listed securities and capital-return actions such as share repurchase programs.
RBA filings also include definitive proxy materials and Form 8-K reports covering annual and special meeting votes, director elections, board composition, executive compensation, shareholder proposals and other governance matters. Material-event filings describe financial results, shareholder voting outcomes, capital-structure disclosures and corporate actions affecting the company’s common shares and related rights.
RB Global Inc. director reports dividend-equivalent awards on Form 4. A board member of RB Global Inc. (RBA) disclosed three acquisitions of derivative securities on 12/17/2025, all at a price of $0. These are dividend equivalent rights tied to existing deferred share units and restricted share units, each representing the economic equivalent of one common share.
The director acquired 102 dividend equivalent rights related to deferred share units, bringing total beneficial ownership of these derivative securities to 4,566 held directly. In addition, the director acquired 10 dividend equivalent rights linked to a 2024 restricted share unit grant, for a total of 72, and 7 similar rights linked to a 2025 restricted share unit grant, for a total of 20. These rights become exercisable and payable in line with the underlying deferred or restricted share units.
RB Global Inc. director reported routine equity-related transactions involving dividend equivalent rights tied to existing awards. On 12/17/2025, the reporting person acquired 7 dividend equivalent rights related to deferred share units, 8 rights related to 2024 restricted share units, and 6 rights related to 2025 restricted share units, all at a price of $0 per right.
Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable and payable in step with the underlying deferred share units or restricted share units.
RB Global Inc. reported an insider equity compensation change for its Chief People Officer, Jennifer Laura Schmit, via a Form 4. On 12/17/2025, she acquired dividend equivalent rights linked to past restricted share unit (RSU) grants. These include 6 dividend equivalent rights tied to the 2024 RSU grant and 5 dividend equivalent rights tied to the 2025 RSU grant, each representing the economic equivalent of one RBA common share at an exercise price of $0. The rights become exercisable proportionately with the underlying RSUs. Following the transactions, she beneficially owned 24 derivative securities related to the 2024 RSUs and 14 related to the 2025 RSUs, all held directly.
RB Global Inc. reported an insider equity update for its Chief Accounting Officer, Christopher Carlson. On December 17, 2025, Carlson received additional dividend equivalent rights linked to previously granted restricted share units (RSUs).
The filing shows awards of dividend equivalent rights that correspond to 4 common shares tied to 2023 RSUs, 7 common shares tied to 2024 RSUs, and 3 common shares tied to 2025 RSUs. These instruments carry an exercise price of $0 and represent the economic equivalent of one RB Global common share each.
After these transactions, Carlson beneficially owned 40 such derivative rights related to the 2023 RSUs, 61 related to the 2024 RSUs, and 9 related to the 2025 RSUs, all held directly. The dividend equivalent rights become exercisable proportionately with the underlying RSUs.
RB Global Inc. reported an insider equity-related transaction by its Chief Legal Officer, who filed individually. On 12/17/2025, the officer acquired dividend equivalent rights tied to prior restricted share unit (RSU) grants. These derivative securities give a contingent right to receive the economic equivalent of one RB Global common share for each right.
The officer received 3 dividend equivalent rights related to 2023 RSUs, 4 related to 2024 RSUs, and 5 related to 2025 RSUs, all at an exercise price of $0 and coded as acquisitions. Following these transactions, the officer beneficially owned 31, 30, and 15 derivative securities for the 2023, 2024, and 2025 RSU-linked rights, respectively. These rights become exercisable proportionately with the underlying RSUs.
RB Global Inc. officer and Chief Operations Officer reported new derivative awards tied to existing restricted share units. On 12/17/2025, the insider acquired 22 dividend equivalent rights linked to the 2024 RSU grant and 13 dividend equivalent rights linked to the 2025 RSU grant, each at a price of $0. Each dividend equivalent right represents the economic equivalent of one RBA common share and becomes exercisable proportionately with the related RSUs. Following these transactions, the insider held 106 dividend equivalent rights related to 2024 RSUs and 36 related to 2025 RSUs, all owned directly.
RB Global Inc. chief financial officer reports dividend equivalent rights tied to RSUs. On December 17, 2025, the company’s CFO, identified as the reporting person on this Form 4, acquired additional derivative securities in the form of dividend equivalent rights linked to prior restricted share unit grants. These include 37 dividend equivalent rights related to the 2024 RSU grant and 28 dividend equivalent rights related to the 2025 RSU grant, each representing the economic equivalent of one RB Global common share with an exercise price of $0. Following these transactions, the reporting person beneficially owned 262 dividend equivalent rights associated with the 2024 RSUs and 111 dividend equivalent rights associated with the 2025 RSUs, all held directly.
RB Global Inc. reported an insider equity compensation update for its Chief Executive Officer, James F. Kessler. On 12/17/2025, Kessler received new derivative awards in the form of dividend equivalent rights tied to prior restricted share unit (RSU) grants. These awards cover 52 rights related to 2023 RSUs, 79 rights related to 2024 RSUs, and 139 rights related to 2025 RSUs, each at a price of $0.
Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable proportionately with the underlying RSUs. Following these grants, Kessler beneficially owns 568, 561, and 391 dividend equivalent rights associated with the 2023, 2024, and 2025 RSU awards, respectively, reflecting standard equity-based compensation rather than open-market share purchases.
RB Global Inc. director Michael D. Sieger reported routine equity-related transactions involving derivative securities tied to the company’s common shares. On 12/17/2025, he acquired 52 dividend equivalent rights related to his deferred share units and 6 dividend equivalent rights related to his 2025 restricted share units, each at a price of $0. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable in line with the underlying deferred share units or restricted share units. Following these transactions, he held 59 dividend equivalent rights linked to deferred share units and 16 linked to 2025 restricted share units in direct ownership.
RB Global Inc. director reports new dividend equivalent rights
A director of RB Global Inc. reported routine equity-based compensation activity dated 12/17/2025. The filing shows the acquisition of 61 dividend equivalent rights tied to deferred share units, each representing the economic equivalent of one RB Global common share and becoming exercisable and payable at the same time as the deferred share units. Following this transaction, the director holds 1,965 of these derivative securities.
The director also acquired 6 dividend equivalent rights related to the 2025 restricted share unit (RSU) grant, each again linked one-for-one to RB Global common shares and becoming exercisable in proportion to the underlying RSUs. After this transaction, the director holds 16 such RSU-related dividend equivalent rights. All of these awards were reported at an exercise price of $0, reflecting their nature as equity incentives rather than open-market purchases.